Cell Therapy Market Opportunity for CMOs – 2018 Edition

List Price: US 4,995

*This report is included at no extra cost for STRATEGIC ADVANTAGE clients, and is accessible in the Trend Reports section here. Learn more about PharmSource STRATEGIC ADVANTAGE outsourcing intelligence portal.

This PharmSource Trend Report will explore whether the bio/pharma industry is adequately prepared for future cell therapy developments and whether pharma companies and CDMOs are making appropriate investments in the capacity and technology to support the coming opportunity. In particular, this Trend Report seeks to achieve the following objectives:

a. To describe and evaluate the cell therapy market opportunity;

b. To describe and address the adequacy of the network of CDMOs that manufacture for the cell therapy market, both clinical and commercial;

c. To assess the outlook for buyers and sellers of contract manufacturing services for cell therapies, including the supply/demand balance.

Who should buy this report?
This 35-page report gives important, expert insight you won’t find in any other source. 16 tables and figures throughout the report illustrate major points and trends. This report is required reading for:

  • CMO executives who must have deep understanding of the Cell Therapy marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Pharmaceutical and Biotech companies involved in the development of Cell Therapies or Cell Therapy technologies.
  • Pharmaceutical and Biotech companies involved in the development of Cell Therapies or Cell Therapy technologies.

Published June 2018